BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 31445183)

  • 1. T Cell Transcriptional Profiling and Immunophenotyping Uncover LAG3 as a Potential Significant Target of Immune Modulation in Multiple Myeloma.
    Lucas F; Pennell M; Huang Y; Benson DM; Efebera YA; Chaudhry M; Hughes T; Woyach JA; Byrd JC; Zhang S; Jones D; Guan X; Burd CE; Rosko AE
    Biol Blood Marrow Transplant; 2020 Jan; 26(1):7-15. PubMed ID: 31445183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-cell Exhaustion in Multiple Myeloma Relapse after Autotransplant: Optimal Timing of Immunotherapy.
    Chung DJ; Pronschinske KB; Shyer JA; Sharma S; Leung S; Curran SA; Lesokhin AM; Devlin SM; Giralt SA; Young JW
    Cancer Immunol Res; 2016 Jan; 4(1):61-71. PubMed ID: 26464015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional regulatory T cells are collected in stem cell autografts by mobilization with high-dose cyclophosphamide and granulocyte colony-stimulating factor.
    Condomines M; Quittet P; Lu ZY; Nadal L; Latry P; Lopez E; Baudard M; Requirand G; Duperray C; Schved JF; Rossi JF; Tarte K; Klein B
    J Immunol; 2006 Jun; 176(11):6631-9. PubMed ID: 16709821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conventional Treatment for Multiple Myeloma Drives Premature Aging Phenotypes and Metabolic Dysfunction in T Cells.
    Cooke RE; Quinn KM; Quach H; Harrison S; Prince HM; Koldej R; Ritchie D
    Front Immunol; 2020; 11():2153. PubMed ID: 33013907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LAG3 and PD1 Regulate CD8+ T Cell in Diffuse Large B-cell Lymphoma Patients.
    Liu Y; Guo X; Zhan L; Wang L; Wang X; Jiang M
    Comput Math Methods Med; 2021; 2021():4468140. PubMed ID: 34422089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cells in multiple myeloma display features of exhaustion and senescence at the tumor site.
    Zelle-Rieser C; Thangavadivel S; Biedermann R; Brunner A; Stoitzner P; Willenbacher E; Greil R; Jöhrer K
    J Hematol Oncol; 2016 Nov; 9(1):116. PubMed ID: 27809856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Expression Level of PD1 by Tumor-Infiltrating CD8
    Kim HD; Song GW; Park S; Jung MK; Kim MH; Kang HJ; Yoo C; Yi K; Kim KH; Eo S; Moon DB; Hong SM; Ju YS; Shin EC; Hwang S; Park SH
    Gastroenterology; 2018 Dec; 155(6):1936-1950.e17. PubMed ID: 30145359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas.
    Zhou G; Sprengers D; Boor PPC; Doukas M; Schutz H; Mancham S; Pedroza-Gonzalez A; Polak WG; de Jonge J; Gaspersz M; Dong H; Thielemans K; Pan Q; IJzermans JNM; Bruno MJ; Kwekkeboom J
    Gastroenterology; 2017 Oct; 153(4):1107-1119.e10. PubMed ID: 28648905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple myeloma patients in long-term complete response after autologous stem cell transplantation express a particular immune signature with potential prognostic implication.
    Arteche-López A; Kreutzman A; Alegre A; Sanz Martín P; Aguado B; González-Pardo M; Espiño M; Villar LM; García Belmonte D; de la Cámara R; Muñoz-Calleja C
    Bone Marrow Transplant; 2017 Jun; 52(6):832-838. PubMed ID: 28368375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in levels of CD28-/CD8+ suppressor cell precursor and CD45RO+/CD4+ memory T lymphocytes in the peripheral blood of multiple sclerosis patients.
    Crucian B; Dunne P; Friedman H; Ragsdale R; Pross S; Widen R
    Clin Diagn Lab Immunol; 1995 Mar; 2(2):249-52. PubMed ID: 7697540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lenalidomide consolidation and maintenance therapy after autologous stem cell transplant for multiple myeloma induces persistent changes in T-cell homeostasis.
    Clave E; Douay C; Coman T; Busson M; Bompoint C; Moins-Teisserenc H; Glauzy S; Carmagnat M; Gorin NC; Toubert A; Garderet L
    Leuk Lymphoma; 2014 Aug; 55(8):1788-95. PubMed ID: 24237448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased LAG3 expression on T effector cells and regulatory T cells in SAA.
    Sun Y; Liu C; Jiao T; Xie N; Wang H; Qi W; Shao Z
    Int J Hematol; 2020 Dec; 112(6):757-763. PubMed ID: 32785818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Immune-Regulatory Receptor Expression on Effector T Cells as Early Indicators of Relapse Following Autologous Stem Cell Transplantation for Multiple Myeloma.
    Lee L; Alrasheed N; Khandelwal G; Fitzsimons E; Richards H; Wilson W; Chavda SJ; Henry J; Conde L; De Massy MR; Chin M; Galas-Filipowicz D; Herrero J; Chain B; Quezada SA; Yong K
    Front Immunol; 2021; 12():618610. PubMed ID: 33717112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fully immunocompetent CD8+ T lymphocytes are present in autologous haematopoietic stem cell transplantation recipients despite an ineffectual T-helper response.
    Bandera A; Trabattoni D; Pacei M; Fasano F; Suardi E; Cesari M; Marchetti G; Pogliani EM; Franzetti F; Clerici M; Gori A
    PLoS One; 2008; 3(10):e3616. PubMed ID: 18974880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination immunotherapy after ASCT for multiple myeloma using MAGE-A3/Poly-ICLC immunizations followed by adoptive transfer of vaccine-primed and costimulated autologous T cells.
    Rapoport AP; Aqui NA; Stadtmauer EA; Vogl DT; Xu YY; Kalos M; Cai L; Fang HB; Weiss BM; Badros A; Yanovich S; Akpek G; Tsao P; Cross A; Mann D; Philip S; Kerr N; Brennan A; Zheng Z; Ruehle K; Milliron T; Strome SE; Salazar AM; Levine BL; June CH
    Clin Cancer Res; 2014 Mar; 20(5):1355-65. PubMed ID: 24520093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re-infused autologous graft natural killer cells correlates with absolute lymphocyte count recovery after autologous stem cell transplantation.
    Porrata LF; Gastineau DA; Padley D; Bundy K; Markovic SN
    Leuk Lymphoma; 2003 Jun; 44(6):997-1000. PubMed ID: 12854901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased exhausted CD8
    Tan J; Chen S; Huang J; Chen Y; Yang L; Wang C; Zhong J; Lu Y; Wang L; Zhu K; Li Y
    Asia Pac J Clin Oncol; 2018 Oct; 14(5):e266-e274. PubMed ID: 29943497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helper T cells (CD3 + /CD4 + ) within the autologous peripheral blood stem cell graft positively correlate with event free survival of multiple myeloma patients.
    Schmidmaier R; Oversohl N; Schnabel B; Straka C; Emmerich B
    Exp Oncol; 2008 Sep; 30(3):240-3. PubMed ID: 18806749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunophenotyping of blood lymphocytes at birth, during childhood, and during adulthood in HIV-1-uninfected Ethiopians.
    Tsegaye A; Wolday D; Otto S; Petros B; Assefa T; Alebachew T; Hailu E; Adugna F; Measho W; Dorigo W; Fontanet AL; van Baarle D; Miedema F
    Clin Immunol; 2003 Dec; 109(3):338-46. PubMed ID: 14697749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic analysis of lymphocytes and monocytes/macrophages in peripheral blood and bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis.
    Wahlström J; Berlin M; Sköld CM; Wigzell H; Eklund A; Grunewald J
    Thorax; 1999 Apr; 54(4):339-46. PubMed ID: 10092696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.